BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, April 27, 2022 (WORLD NEWSWIRE)– by means of NewMediaWire– BioCorRx Inc. (OTCQB: BICX) (the “Business”), a designer and …